Finerenone and Atrial Fibrillation in Heart Failure
Shingo Matsumoto, Sanjiv J. Shah, Brian Lee Claggett, Johann Bauersachs et al.
Citations
11 citations
Journal
JAMA Cardiology
Topics
Heart Failure Treatment and Management
Field-Weighted Citation Impact (FWCI)
15.27
article
Finerenone and Atrial Fibrillation in Heart Failure
Shingo Matsumoto, Sanjiv J. Shah, Brian Lee Claggett, Johann Bauersachs, Pardeep S. Jhund, James Lay‐Flurrie, John J.V. McMurray, Alasdair Henderson, Bertram Pitt, Meike Brinker, Scott David Solomon, Josep Comín‐Colet, Muthiah Vaduganathan, Ovidiu Chioncel, Carolyn S.P. Lam, Shelley R. Zieroth, Morten Schou, Michele Senni, Adriaan A. Voors, Akshay S. Desai, Markus F. Scheerer, Faiez Zannad, Flaviana Amarante
article en
11 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA CardiologyVol. 10(7)
Institutions
Northwestern University (US), Brigham and Women's Hospital (US), Toho University (JP), Harvard University (US), Inserm (FR), Carol Davila University of Medicine and Pharmacy (RO), National University of Singapore (SG), University of Groningen (NL), National and Kapodistrian University of Athens (GR), University of Michigan (US), Bellvitge University Hospital (ES), Gentofte Hospital (DK), British Heart Foundation (GB), Medizinische Hochschule Hannover (DE), Institut d'Investigació Biomédica de Bellvitge (ES), Ospedale Papa Giovanni XXIII (IT), National University Heart Centre Singapore (SG), National Heart Centre Singapore (SG), Bayer (United Kingdom) (GB), University of Manitoba (CA), University of Milano-Bicocca (IT), Bayer (Germany) (DE), Universitat de Barcelona (ES), University of Glasgow (GB), Université de Lorraine (FR)
Funders
American Heart Association, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, Alnylam Pharmaceuticals, Impulse Dynamics, Abiomed, European Commission, University of Glasgow, Novo Nordisk, Servier, Norgine, National Institutes of Health, Medical Research Council, National Medical Research Council